Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells May be Induced by Interactions Between Receptor Tyrosine Kinases and ERα-66.

Recent patents on anti-cancer drug discovery - 1 Jan 2018

Farahmand Leila, Mansouri Sepideh, Jafarbeik-Iravani Narges, Teymourzadeh Azin, Majidzadeh-A Keivan

Abstract excerpt

BACKGROUND: Tamoxifen is widely administered for patients with estrogen receptor-positive breast cancer. Despite many patients benefiting from Tamoxifen as an effective anti-hormonal agent in adjuvant therapy, a noticeable number of patients tend to develop resistance. OBJECTIVE: The aim of this study was to shed light upon the molecular mechanisms associated with Tamoxifen resistance which can help improve...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Estrogen Receptor alpha

Share to MCF-7 Cells

Share to Patents as Topic

Share to Receptor, ErbB-2

Share to Tamoxifen

Source

Identifiers

PMID: 29512469
DOI: 10.2174/1574892813666180305164634

Genes

EGFR
HOXB7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells May be Induced by Interactions Between Receptor Tyrosine Kinases and ERα-66.PMID 29512469Read ↗

An Insight Into the Cancer Stem Cell Survival Pathways Involved in Chemoresistance in Triple-Negative Breast CancerSemantic proximity Read ↗

Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goalsSemantic proximity Read ↗

Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required.Semantic proximity Read ↗

An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancerSemantic proximity Read ↗

Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.Semantic proximity Read ↗

Translational drugs targeting cancer stem cells in triple-negative breast cancerSemantic proximity Read ↗

Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic ImplicationsSemantic proximity Read ↗

Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.Semantic proximity Read ↗

Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.Semantic proximity Read ↗

Treatment Resistance in Stem Cells and Breast CancerSemantic proximity Read ↗

Breast cancer stem cells: A review of their characteristics and the agents that affect themSemantic proximity Read ↗

Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.